Clinical Medicine


  Listando 20 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   89   News   0   Policy
Article PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma Migden, M. R.; Rischin, D.; Schmults, C. D.; Guminski, A.; Hauschild, A.; Lewis, K. D.; Chung, C. H.; Hernandez-Aya, L.; Lim, A. M.; Chang, A. L. S.; Rabinowits, G.; Thai, A. A.; Dunn, L. A.; Hughes, B. G. M.; Khushalani, N. I.; Modi, B.; Schadendorf, D.; NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2018) DOI / 10.1056/nejmoa1805131 Green published, Bronze
Mentions   0   Wikipedia   61   News   0   Policy
Article Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial Rodon, Jordi; Soria, Jean-Charles; Berger, Raanan; Miller, Wilson H.; Rubin, Eitan; Kugel, Aleksandra; Tsimberidou, Apostolia; Saintigny, Pierre; Ackerstein, Aliza; Brana, Irene; Loriot, Yohann; Afshar, Mohammad; Miller, Vincent; Wunder, Fanny; Bresson, Ca NATURE MEDICINE 1078-8956 (2019) DOI / 10.1038/s41591-019-0424-4 Green accepted
Mentions   0   Wikipedia   5   News   0   Policy
Letter Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal Tamborero, David; Dienstmann, Rodrigo; Rachid, Maan Haj; Boekel, Jorrit; Baird, Richard; Brana, Irene; de Petris, Luigi; Yachnin, Jeffrey; Massard, Christophe; Opdam, Frans L.; Schlenk, Richard; Vernieri, Claudio; Garralda, Elena; Masucci, Michele; Villalo NATURE MEDICINE 1078-8956 (2020) DOI / 10.1038/s41591-020-0969-2
Mentions   0   Wikipedia   16   News   0   Policy
Article Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial Oaknin, Ana; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Brana, Irene; Bidard, Francois-Clement; Goldman, Jonathan; Alvarez, Edwin A.; Boni, Valentina; ElNaggar, Adam C.; Passalacqua, Rodolfo; Do, Khanh T. M.; Santin, Alessandro D.; Keyvanjah, GYNECOLOGIC ONCOLOGY 0090-8258 (2020) DOI / 10.1016/j.ygyno.2020.07.025 Gold other
Mentions   0   Wikipedia   6   News   0   Policy
Article Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival Lazar, Vladimir; Magidi, Shai; Girard, Nicolas; Savignoni, Alexia; Martini, Jean-Francois; Massimini, Giorgio; Bresson, Catherine; Berger, Raanan; Onn, Amir; Raynaud, Jacques; Wunder, Fanny; Berindan-Neagoe, Ioana; Sekacheva, Marina; Brana, Irene; Taberner NPJ PRECISION ONCOLOGY (2021) DOI / 10.1038/s41698-021-00171-6 Gold DOAJ, Green published
Mentions   0   Wikipedia   5   News   0   Policy
Article Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations Ho, Alan L.; Brana, Irene; Haddad, Robert; Bauman, Jessica; Bible, Keith; Oosting, Sjoukje; Wong, Deborah J.; Ahn, Myung-Ju; Boni, Valentina; Even, Caroline; Fayette, Jerome; Flor, Maria Jose; Harrington, Kevin; Hong, David S.; Kim, Sung-Bae; Licitra, Lisa JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2021) DOI / 10.1200/jco.20.02903 Green published, Hybrid
Mentions   0   Wikipedia   2   News   0   Policy
Article A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors Ligero, Marta; Garcia-Ruiz, Alonso; Viaplana, Cristina; Villacampa, Guillermo; Raciti, Maria, V; Landa, Jaid; Matos, Ignacio; Martin-Liberal, Juan; Ochoa-de-Olza, Maria; Hierro, Cinta; Mateo, Joaquin; Gonzalez, Macarena; Morales-Barrera, Rafael; Suarez, Cr RADIOLOGY 0033-8419 (2021) DOI / 10.1148/radiol.2021200928
Mentions   0   Wikipedia   0   News   0   Policy
Article Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria Matos, Ignacio; Martin-Liberal, Juan; Garcia-Ruiz, Alonso; Hierro, Cinta; Ochoa de Olza, Maria; Viaplana, Cristina; Azaro, Analia; Vieito, Maria; Brana, Irene; Mur, Gemma; Ros, Javier; Mateos, Jose; Villacampa, Guillermo; Berche, Roger; Oliveira, Mafalda; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-2226 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials Dienstmann, Rodrigo; Garralda, Elena; Aguilar, Susana; Sala, Gemma; Viaplana, Cristina; Ruiz-Pace, Fiorella; Gonzalez-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Ramos Masdeu, Laia; Mancuso, Francesco; Fasani, Roberta; Jimenez, Jose; Mart JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.19.00398 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials Matos, Ignacio; Villacampa, Guillermo; Hierro, Cinta; Martin-Liberal, Juan; Berche, Roger; Pedrola, Anna; Brana, Irene; Azaro, Analia; Vieito, Maria; Saavedra, Omar; Gardeazabal, Itziar; Hernando-Calvo, Alberto; Alonso, Guzman; Galvao, Vladimir; de Olza, M EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.05.040 Hybrid
Mentions   0   Wikipedia   1   News   0   Policy
Article Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC The Phase 2 CONDOR Randomized Clinical Trial Siu, Lillian L.; Even, Caroline; Mesia, Ricard; Remenar, Eva; Daste, Amaury; Delord, Jean-Pierre; Krauss, Juergen; Saba, Nabil F.; Nabell, Lisle; Ready, Neal E.; Brana, Irene; Kotecki, Nuria; Zandberg, Dan P.; Gilbert, Jill; Mehanna, Hisham; Bonomi, Marcel JAMA ONCOLOGY 2374-2437 (2019) DOI / 10.1001/jamaoncol.2018.4628 Green published
Mentions   0   Wikipedia   2   News   0   Policy
Article Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma Moreno, V; Sepulveda, J. M.; Vieito, M.; Hernandez-Guerrero, T.; Doger, B.; Saavedra, O.; Ferrero, O.; Sarmiento, R.; Arias, M.; De Alvaro, J.; Di Martino, J.; Zuraek, M.; Sanchez-Perez, T.; Aronchik, I; Filvaroff, E. H.; Lamba, M.; Hanna, B.; Nikolova, Z. ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.03.294 Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer Rischin, Danny; Gil-Martin, Marta; Gonzalez-Martin, Antonio; Brana, Irene; Hou, June Y.; Cho, Daniel; Falchook, Gerald S.; Formenti, Silvia; Jabbour, Salma; Moore, Kathleen; Naing, Aung; Papadopoulos, Kyriakos P.; Baranda, Joaquina; Fury, Wen; Feng, Minjie GYNECOLOGIC ONCOLOGY 0090-8258 (2020) DOI / 10.1016/j.ygyno.2020.08.026 Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study Olmedo, Maria Eugenia; Forster, Martin; Moreno, Victor; Lopez-Criado, Maria Pilar; Brana, Irene; Flynn, Michael; Doger, Bernard; De Miguel, Maria; Lopez-Vilarino, Jose Antonio; Nunez, Rafael; Kahatt, Carmen; Cullell-Young, Martin; Zeaiter, Ali; Calvo, Emil INVESTIGATIONAL NEW DRUGS 0167-6997 (2021) DOI / 10.1007/s10637-020-01025-x Green published, Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with >= 25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy Zandberg, Dan P.; Algazi, Alain P.; Jimeno, Antonio; Good, James S.; Fayette, Jerome; Bouganim, Nathaniel; Ready, Neal E.; Clement, Paul M.; Even, Caroline; Jang, Raymond W.; Wong, Stuart; Keilholz, Ulrich; Gilbert, Jill; Fenton, Moon; Brana, Irene; Henry, EUROPEAN JOURNAL OF CANCER 0959-8049 (2019) DOI / 10.1016/j.ejca.2018.11.015 Green published, Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Review New clinical trial designs in the era of precision medicine Garralda, Elena; Dienstmann, Rodrigo; Piris-Gimenez, Alejandro; Brana, Irene; Rodon, Jordi; Tabernero, Josep MOLECULAR ONCOLOGY 1574-7891 (2019) DOI / 10.1002/1878-0261.12465 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours Ameratunga, Malaka; Brana, Irene; Bono, Petri; Postel-Vinay, Sophie; Plummer, Ruth; Aspegren, John; Korjamo, Timo; Snapir, Amir; de Bono, Johann S. BRITISH JOURNAL OF CANCER 0007-0920 (2020) DOI / 10.1038/s41416-020-01077-z Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Data Paper Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Babiker, Hani; Brana, Irene; Mahadevan, Daruka; Owonikoko, Taofeek; Calvo, Emiliano; Rischin, Danny; Moreno, Victor; Papadopoulos, Kyriakos P.; Crittenden, Marka; Formenti, Silvia; Giralt, Jordi; Garrido, Pilar; Soria, Ainara; Hervas-Moron, Asuncion; Mohan ONCOLOGIST 1083-7159 (2021) DOI / 10.1002/onco.13810 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer Wainberg, Zev A.; Alsina, Maria; Soares, Heloisa P.; Brana, Irene; Britten, Carolyn D.; Del Conte, Gianluca; Ezeh, Patrick; Houk, Brett; Kern, Kenneth A.; Leong, Stephen; Pathan, Nuzhat; Pierce, Kristen J.; Siu, Lillian L.; Vermette, Jennifer; Tabernero, J TARGETED ONCOLOGY 1776-2596 (2017) DOI / 10.1007/s11523-017-0530-5 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial Colevas, A. D.; Bahleda, R.; Braiteh, F.; Balmanoukian, A.; Brana, I.; Chau, N. G.; Sarkar, I.; Molinero, L.; Grossman, W.; Kabbinavar, F.; Fasso, M.; O'Hear, C.; Powderly, J. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy411 Gold other

Más rankings

InfluScience